BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1697094)

  • 21. [Results of the treatment of primary gastric lymphomas--chemotherapy after gastrectomy].
    Takagi T; Oguro M; Omori Y; Honda I; Fujita Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2601-4. PubMed ID: 6210056
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radiation therapy for unresected gastric lymphoma].
    Kataoka M; Kawamura M; Kimura Y; Itoh H; Tsuda T; Komatsu A; Hamamoto K
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):1013-8. PubMed ID: 2391441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
    Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
    Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study.
    Willich NA; Reinartz G; Horst EJ; Delker G; Reers B; Hiddemann W; Tiemann M; Parwaresch R; Grothaus-Pinke B; Kocik J; Koch P
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):895-901. PubMed ID: 10705011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Total gastrectomy after VEPA therapy in a case of primary gastric lymphoma (stage III of Naqvi's clinical staging)].
    Ishiguro T; Furumi K; Mukunoki Y; Nakamoto K; Hatano Y; Ookubo S; Matsuoka T
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3461-5. PubMed ID: 2802640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
    Diehl V; Franklin J; Hasenclever D; Tesch H; Pfreundschuh M; Lathan B; Paulus U; Sieber M; Rueffer JU; Sextro M; Engert A; Wolf J; Hermann R; Holmer L; Stappert-Jahn U; Winnerlein-Trump E; Wulf G; Krause S; Glunz A; von Kalle K; Bischoff H; Haedicke C; Duehmke E; Georgii A; Loeffler M
    J Clin Oncol; 1998 Dec; 16(12):3810-21. PubMed ID: 9850026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
    O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
    J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas.
    Steinke B; Krüger HU; Kraft H; Heim ME; Günther E; Arnold H; Busch FW
    Blut; 1988 Jun; 56(6):269-71. PubMed ID: 2454690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of conventional chemotherapy in aggressive lymphomas.
    Cunningham D; Hepplestone A; Gilchrist NL; Dagg JH; Evans IL; Soukop M
    Postgrad Med J; 1987 Jan; 63(735):11-5. PubMed ID: 2444960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
    Takenaka T; Maruyama K; Kinoshita T; Sasako M; Sano T; Katai H; Matsuno Y
    Br J Cancer; 1997; 76(11):1484-8. PubMed ID: 9400946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
    Schlembach PJ; Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1107-10. PubMed ID: 11072169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical aspects and therapy of anaplastic T-zone lymphoma].
    Bartels H; Schneider B; Feller AC
    Dtsch Med Wochenschr; 1984 Jul; 109(28-29):1112-6. PubMed ID: 6204832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
    J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).
    Coiffier B; Bryon PA; Berger F; Archimbaud E; Ffrench M; Extra JM; Guyotat D; Fiere D; Gentilhomme O; Magaud JP
    J Clin Oncol; 1986 Feb; 4(2):147-53. PubMed ID: 2418166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary gastric lymphoma--the experience of a general hospital.
    Economopoulos T; Alexopoulos C; Stathakis N; Styloyannis S; Dervenoulas J; Tsousis S; Raptis S
    Br J Cancer; 1985 Sep; 52(3):391-7. PubMed ID: 3840030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of primary gastric non-Hodgkin's lymphoma with chemotherapy and radiotherapy.
    Tsukada K; Arima K; Ohosone Y; Hanada T; Mita S; Harada K; Matsuoka Y; Irimajiti S; Fukuda J
    Intern Med; 1992 Mar; 31(3):368-72. PubMed ID: 1377061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
    Diehl V; Franklin J; Pfreundschuh M; Lathan B; Paulus U; Hasenclever D; Tesch H; Herrmann R; Dörken B; Müller-Hermelink HK; Dühmke E; Loeffler M;
    N Engl J Med; 2003 Jun; 348(24):2386-95. PubMed ID: 12802024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.